Protozoa Infections
Unicellular eukaryotic organisms – part of animal kingdom
Malaria:
• caused by Plasmodium faliciparum, P. vivax, P. ovale and P. milariae; transmitted by bite of anopheline mosquitoes; 7-14 day incubation; most will present within 2 months
• WHO campaigns have reduced incidence; over 2000 cases annually in Britain (mostly travellers)
• multiples in red blood cells haemolysis, stasis of red blood cells and release of cytokines
• mainly in hot wet climates of tropics and subtropics
• prodrome of headache, muscle aches, headache, anorexia progresses to sudden coldness, rigor, high fever, vomiting, sweats
• 1% fatal (mostly children); other complications – cerebral infection; hypoglycaemia; renal failure; pulmonary oedema
• treatment – most now resistant to chloroquine; primaquine; quinine; pryimethamine; mefloquine
Amoebiasis:
• due to Entamoeba histolytica – intestinal amoeba spread between humans by its cyst
• causes dysentery – up to several years after infection; diarrhoea (mild at first) that progresses to being profuse and bloody
• responds quickly to metromidazole
Giardiasis:
• caused by Giardia intestinalis
• more common in tropics
• 1-3 week incubation diarrhoea, abdominal pain, weakness, anorexia, nausea, vomiting
• treatment – tinidazole, metronindazole
Toxoplasmosis:
• caused by Toxoplasma gondii. Route is via GI tract, lungs or broken skin; from cats (hosts) or infected food
• most infections are asymptomatic
Leishmaniasis:
• due to Leishmania protozoa spread by sandflies in Africa, India, South American, Middle East.
• Cutaneous leishmaniasis – lesion develops at site of bite – starts as itchy papule crust falls off ulcer; most heal
• Mucocutaneous leishmaniasis – primary skin lesion spreads to mucosa of nose or mouth; can result in pneumonia
• Visceral leishmaniasis – results in hyperpigmentation of face, hands, feet and abdomen); 52% present with burning feet – other presenting features include fever, splenomegaly, weight loss, sweats, fatigue, decreased appetite, cough
We have not yet got to this page. We will eventually. Please contact us if you have something to contribute to it or sign up for our newsletter or like us on Facebook and Instagram or follow us on Twitter.![]() |
Page last updated:
Comments are closed.